Campaign Overview for www.moriskyscale.com - “The MAAP to Better Health”


The campaign will focus on educating healthcare providers, patients, and caregivers about the Medication Adherence Action Plan (MAAP), powered by Remote Patient Monitoring (RPM), and how it integrates the Morisky Scale to improve patient medication adherence. The ultimate goal of this campaign is to emphasize the structured, step-by-step journey from low adherence to high adherence, with each RPM acting as a building block towards better health outcomes.


Campaign Objectives:


1. Raise Awareness: Educate healthcare providers and patients about the importance of medication adherence and how MAAP, combined with RPM and the Morisky Scale, can systematically improve adherence.
2. Drive Engagement: Encourage healthcare providers to adopt the MAAP framework by emphasizing its effectiveness and ease of implementation through RPM tools.
3. Improve Patient Outcomes: Demonstrate how personalized adherence action plans improve patient adherence over time, leading to better health outcomes.
4. Foster Trust: Position www.moriskyscale.com as a trusted resource for improving medication adherence through scientific methods and cutting-edge monitoring.


Target Audiences:


1. Healthcare Providers: Physicians, nurses, pharmacists, and care teams responsible for managing patient medication.
2. Patients with Chronic Conditions: Especially those requiring long-term medication management (e.g., diabetes, hypertension, etc.).
3. Pharmacies and Health Systems: Institutions aiming to reduce hospital readmissions and improve patient outcomes through effective adherence strategies.
4. Caregivers: Individuals supporting patients with their medication regimen.


Campaign Strategy:


1. Educational Content Campaign (“MAAP to Better Health”):


• Whitepapers & E-books: Develop a whitepaper titled “The MAAP to Medication Adherence: How RPM and the Morisky Scale Transform Patient Outcomes.” This document will be made available for download after signing up, generating leads.
• Webinars & Virtual Events: Host educational webinars targeted at healthcare professionals on how to integrate MAAP and RPM into their practice.
• Blog Series: A content series on www.moriskyscale.com covering:
• “What is the MAAP and Why Medication Adherence Matters?”
• “Understanding the Morisky Score: The Key to Improving Adherence”
• “How Remote Patient Monitoring Enhances Medication Adherence”
• “Adherence Action Plans: Building Responsibility and Engagement”
• Case Studies: Showcase real-world examples of patients improving from low to high adherence using the MAAP and RPM, showing tangible health outcomes.


2. Interactive Adherence Journey Tools:


• MAAP Calculator: An interactive tool that allows patients and providers to input Morisky Scores and create a personalized action plan for adherence improvement. The tool will show the RPM milestones, suggested interventions, and expected progress over time.
• Patient Progress Dashboard: An online dashboard accessible by both healthcare providers and patients. This would track the patient’s adherence level (low, medium, high) and provide feedback based on RPM intervals.
• Gamified Adherence Program: Patients could be incentivized to move from one adherence level to another by completing set milestones and earning badges or rewards.


3. Email and Social Media Campaigns:


• Provider Outreach: Email campaigns targeting healthcare providers with compelling statistics on the impact of medication adherence on patient outcomes, and how RPM with MAAP improves compliance rates.
• Patient-Centered Social Campaign: Use social media to share stories of patients who improved their health outcomes by following the MAAP. Incorporate infographics about medication adherence and tips for staying on track.
• Monthly Adherence Newsletter: Provide updates on medication adherence research, tips for improving adherence, and success stories from MAAP and RPM users.


4. Partnerships and Affiliations:


• Collaborate with Pharmacies and Health Systems: Offer educational workshops or in-service training to pharmacies and health systems on implementing RPM to drive adherence.
• Affiliation with Patient Advocacy Groups: Work with advocacy groups for chronic conditions (e.g., American Diabetes Association, American Heart Association) to highlight MAAP as a patient support tool.
• Collaboration with RPM Technology Providers: Showcase the Morisky Scale on leading RPM platforms that integrate with MAAP for seamless provider-patient interactions.


Messaging:


• For Providers:
• “Enhance Medication Adherence with MAAP: An actionable plan backed by Remote Patient Monitoring and the Morisky Scale.”
• “Identify, Assess, and Improve: Personalized RPM plans that build adherence over time.”
• For Patients:
• “The MAAP to Better Health: Track your medication adherence with real-time feedback.”
• “From Low to High Adherence: Our step-by-step RPM plan helps you take control of your health.”
• For Health Systems:
• “Reduce Readmissions, Improve Outcomes: A scalable solution to medication adherence with MAAP and RPM.”


Key Performance Indicators (KPIs):


• Website Traffic: Measure the increase in traffic to www.moriskyscale.com, particularly to MAAP-related content.
• Lead Generation: Track the number of whitepaper downloads, webinar registrations, and tool usage (e.g., MAAP Calculator).
• Provider Adoption Rate: Measure the number of healthcare providers integrating MAAP and RPM into their practice.
• Patient Engagement: Track patient adherence levels over time through RPM and adherence dashboard usage.


Timeline:


• Month 1: Launch the educational content campaign and promote through email and social media.
• Month 2: Host the first webinar for healthcare providers and release the interactive MAAP Calculator.
• Month 3-6: Implement ongoing email and social campaigns, release patient stories, and continue educational outreach.
• Month 6-12: Measure provider adoption, monitor patient progress, and develop partnerships with health systems.


This integrated approach leverages educational tools, patient empowerment, and provider engagement to promote the Medication Adherence Action Plan (MAAP), ultimately driving long-term improvements in patient adherence and health outcomes.

The Importance of Medication Action Plan in Managing Your HealthLeave a Comment / By Dewayne_Smith / August 10, 2023
A Medication action plan is a customized, systematic approach to medication management that promotes adherence and wellness. It lists all of your prescriptions, their doses, and when and how to take them.
Managing drugs appropriately is essential for good health. Medication management can enhance symptom control, treatment results, and complications. It empowers people to improve their health and quality of life. This blog discusses Medication action plans and health management. We will discuss medication therapy management (MTM) and offer recommendations to help you design and implement a plan.

Understanding Medication Management
Medication Management ensures safe, effective, and appropriate pharmaceutical usage. It involves prescribing, distributing, administering, and monitoring drugs.
Healthcare providers are essential for medication management. They evaluate patients, administer drugs, and track treatment outcomes. Communication between patients and doctors is crucial for drug management.

Challenges and Risks of Poor Medication Management
Medication mistakes, adverse drug responses, treatment failures, and patient safety can result from poor medication administration. Managing many prescriptions, forgetfulness, and misreading drug directions are common issues.
What is a Medication Action Plan?
A medication action plan explains how to follow and manage medications. It promotes proactive health management by tailoring to an individual’s medical needs, lifestyle, and preferences.
Unlike simple drug administration, a drug action plan is more detailed. Setting objectives, resolving obstacles, and actively participating the healthcare team optimizes treatment outcomes.

Creating a Medication Action Plan

• Assess your prescription, over-the-counter, and supplement needs. Know their uses, doses, and side effects.
• Set attainable drug management objectives like increased adherence, side effect reduction, or symptom control.
• Identify medication management issues and devise solutions. This may involve pill organizers, medication regimens, or family assistance.
• Create a detailed plan with your physicians, chemists and nurses. Make sure everyone knows your strategy and can help.

Benefits of Having a Medication Action Plan
A medication action plan has several benefits, improving health management and overall health. Patients can benefit from proactive drug management:

1. Better Treatment Adherence
A well-structured Medical action plan reminds patients to take their pills. Patients are more likely to take their medications if they follow the plan, improving treatment results. Adherence improves drug efficacy, avoiding illness progression and consequences.

2. Better Symptom Management
Patients can better control and relieve their symptoms with a thorough medication plan. Compliance with recommended drugs reduces symptom intensity and frequency, improving quality of life and comfort.

3. Fewer Hospitalisations
Patients can decrease medication-related problems and medical exacerbations by following their medication plan. This can reduce hospitalisations and ER visits, lowering healthcare expenditures and improving health.

4. Better Emotional Health
A Medication action plan helps people to control their health. Effective medication management gives patients a sense of control over their health, improving their well-being and everyday life.

5. Optimized Drug Regimen
Patients and physicians can optimize treatment regimens with an action plan. Improvements in medication coordination and integration reduce drug interactions and negative effects. This optimization ensures the patient’s medications are effective and suitable.

6. Greater Patient-Healthcare Provider Collaboration
A med action plan encourages patient-provider dialogue and collaboration. More personalized and patient-centered treatment results from encouraging patients to disclose drug management issues.

7. Confidence and Empowerment
Patients feel empowered and confident when they actively participate in their treatment with proper plan. This sense of health ownership can promote self-esteem and motivate healthy living and treatment.

8. Medication Error Prevention
Patients can reduce medication mistakes by clearly outlining directions and doses in the plan. Clear instructions help patients take their drugs safely and efficiently, preventing overdoses and missing doses.


Medication Therapy Management (MTM)
Pharmacists offer drug therapy management (MTM) to optimize drug usage and results for patients. It entails assessing drugs, finding and fixing difficulties, and educating patients. MTM improves medication adherence, lowers medication-related issues, and engages patients in their health management.
Benefits of Incorporating MTM in Your Health Management
Incorporating MTM in your health management can lead to better medication outcomes, increased knowledge about your medications, and improved communication with your healthcare team.

Medication Management Tips for Success

1. Arrange your meds safely and easily. Use pill organizers or apps to track doses and refills.
2. Use phone alarms or medication reminder applications to remember to take your meds.
3. Carefully read drug labels and directions. Please ask your chemist or doctor if you have questions.
4. Inform your doctor about adverse symptoms immediately. They can alter your therapy if needed.
5. Know how drugs and supplements interact. Talk to your chemist or doctor to avoid side effects.
6. Avoid accidental consumption and environmental contamination by properly disposing of expired or unused pharmaceuticals. Consult your chemist or local regulations for safe disposal.

Implementing Your Medication Action Plan
Start implementing your medication plan by following the steps you outlined during the creation process.

Monitoring and Reviewing Your Progress
Regularly monitor your progress and make adjustments as needed. Keep track of medication changes, improvements in symptoms, and any challenges faced.

Modifying the Plan as Needed
If your health condition changes or you encounter new challenges, modify your medication plan accordingly. Regularly communicate with your healthcare team to ensure your plan stays up-to-date.

Communicating with Your Healthcare Team
Maintain open communication with your healthcare team, sharing updates and seeking advice whenever necessary. A collaborative approach enhances the effectiveness of your action plan.

Conclusion
Finally, Action plans for medication promote adherence, medication management, and health. By implementing these strategies, people may manage their health and improve medication management and treatment results.
Patients and doctors work together to better understand drug requirements, optimizing regimens and reducing side effects. Medication action plans help people live healthy, happy lives. Drug management and following prescriptions can lead to a better and happier future.
Must Read: Strengthening Bonds: Exploring Family Therapy Goals and Objectives

FAQS
Why Medication Plan Important For Health Management?
A drug action plan is a customized plan to optimize drug management. It lists your drugs, doses, and adherence directions. A well-structured strategy helps you to manage your health, improving treatment adherence, symptom management, and complications.

Why is a Medication Action Plan Different From Ordinary Medication Management?
Regular medication management entails taking prescribed drugs. However, a Medication Action Plan addresses individual health requirements and possible difficulties in a comprehensive manner. It involves goal-setting, healthcare provider collaboration, and proactive health and well-being methods

Key benefits of a Medication Action Plan?
A drug Action Plan improves treatment adherence, symptom control, hospitalisations, drug regimens, healthcare provider collaboration, and empowerment and confidence in health management.

How Does MTM Help My Medical Action Plan?
Pharmacists optimize medicine usage through medicine Therapy Management (MTM). Medication reviews, problem-solving, and patient education make MTM an ideal fit with Medication Action Plans.

How Can I Build and Implement a Successful Medication Plan?
Assessing your medication requirements, creating objectives, detecting possible issues, and including your healthcare team are key to a successful Medication Action Plan. The plan should be evaluated and adjusted as needed based on your health or treatment needs.

:
AbstractAdherence to therapies is a primary determinant of treatment success. Failure to adherence is a serious problem which not only affects the patient but also the health care system. Medication non adherence in patients leads to substantial worsening of disease, death and increased health care costs. A variety of factors are likely to affect adherence. Barriers to adherence could be addressed as patient, provider and health system factors, with interactions among them. Identifying specific barriers for each patient and adopting suitable techniques to overcome them will be necessary to improve medication adherence. Health care professionals such as physicians, pharmacists and nurses have significant role in their daily practice to improve patient medication adherence.

Medication adherence is defined by the World Health Organization as "the degree to which the person’s behavior corresponds with the agreed recommendations from a health care provider."1Though the terms adherence and compliance are synonymously used adherence differs from compliance. Compliance is the extent to which a patient’s behavior matches the prescriber’s advice.2Compliance implies patient obedience to the physician’s authority,3-5 whereas adherence signifies that the patient and physician collaborate to improve the patient’s health by integrating the physician’s medical opinion and the patient’s lifestyle, values and preferences for care.6-8
There are several types of non adherence but most often the categorization is indisputable, and there is a degree of overlap. The first is known as primary non adherence, in which providers write prescription but the medication is never filled or initiated. This type is commonly called non fulfillment adherence.9
A second type of non adherence is called non persistence in which patients decide to stop taking a medication after starting it, without being advised by a health professional to do so. Non persistence is rarely intentional and happens when patients and providers miscommunication about therapeutic plans. Unintentional non adherence arises from capacity and resource limitations that prevent patients from implementing their decisions to follow treatment recommendations (e.g. problems of accessing prescriptions, cost, competing demands etc) and sometimes involves individual constraints (e.g. poor inhaler technique, problems remembering doses etc). Whilst intentional non adherence arises from the beliefs, attitudes and expectations that influence patients’ motivation to begin and persist with the treatment regimen.10
A third type of non adherence is known as non conforming, this type includes a variety of ways in which medication are not taken as prescribed, this behavior can range from skipping doses, to taking medications at incorrect times or at incorrect doses, to even taking more than prescribed.
Rate of adherence is usually reported as the percentage of the prescribed doses of the medication actually taken by the patient over a specified period.11 The extent of non-adherence varies widely, and in different studies it has been recorded as low as 10 percent and as high as 92%.12 Extensive review of the literature reveal that in developed countries adherence to therapies averages 50%.13,14 Approximately half of this non-adherence is intentional, whilst the remainder occurs because patients are either unaware that they are not taking medications as prescribed or the regimen is just too complex.15 Adherence rates are typically higher among patients with acute conditions, as compared against those with chronic conditions.16-18 Studies reveal that patients with chronic illnesses take only ~50% of medications prescribed for those conditions.18,19
The consequence of non adherence is waste of medication, disease progression, reduced functional abilities, a lower quality of life, increased use of medical resources such as nursing homes, hospital visits and hospital admissions.19,20 Economic studies reveal that poor adherence to prescribed regimens can result in serious health consequence which is supported by various studies. For instance in a study conducted by Anon, it was shown that the risk of hospitalization was more than double in patients with diabetes mellitus, hypercholesterolemia, hypertension, or congestive heart failure who were non adherent to prescribed therapies compared with a general population.21Studies conducted among Chronic Obstructive Pulmonary Disease patients have shown that poor adherence to drug therapy and disease management leads to emergency hospitalization.22,23
Medication non adherence can have negative consequences not only for the patient but also for the provider, the physician, and even the medical researchers who are working to establish the value of the medication on the target population. The potential burden of medication non adherence outcomes on health care delivery makes it an important public health concern.13,24,25 Hence, helping people take their medicine appropriately would be a better achievement to avoid higher risk of severe relapses, antibiotic resistance, and preventable hospitalizations.

What influences medication adherence?Non-adherence is a very common phenomenon in all patients with drug taking behavior. Complexity of adherence is the result of an interplay of a range of factors including patient views and attributes, illness characteristics, social contexts, access and service issues.13,26-28
Barriers to the effective use of medicines specifically include poor provider-patient communication, inadequate knowledge about a drug and its use, not being convinced of the need for treatment, fear of adverse effects of the drug, long term drug regimens, complex regimens that require numerous medications with varying dosing schedules,29 cost and access barriers.11,30,31
It has also been observed that patient non adherence varies between and within individuals, as well as across time, recommended behaviors and diseases.32 Adherence to drug therapy varies with patient age group also. In children, adherence to drug therapy is affected due to their dependence on an adult care giver. The literature concerning adherence reports in elderly patients reports that compliance rates range roughly from 38%- 57% with an average rate of less than 45%.33,34
A major reason for non adherence is higher patient-physician discordance leading to decreased patient satisfaction.35-40 Studies report that 40-60% of patients could not correctly report what their physicians expected of them 10-80 minutes after they were provided with the information.41,42Yet another study reported that over 60% of patients interviewed immediately after visiting their doctors misunderstood the directions regarding prescribed medications.43
Non adherence can also occur when the medication regimen is complex which could include improper timing of drug administration, or administration of numerous medications at frequent or unusual times during the day. These patient behavioral factors may or may not be perceived by the physician and results in decreased therapeutic outcome. Most deviations in taking medication occur as omission of doses (rather than additions) or delays in the timing of doses.44,45
Patients most often become non-compliant for chronic diseases, like hypertension, where they do not have any unpleasant symptoms even without strict compliance to medication regimen. Estimates of medication non adherence illustrates that the non adherence percentage is greatest when the patients are symptom-free.43 Seventy seven percent of patients demonstrated high degrees of compliance with their medication regimen when the treatment was designed to cure a disease and only 63% of patients complied when treatment was aimed at prevention. However, when medication was to be taken over a long period, compliance rates dropped dramatically to around 50% for either prevention or cure.33
One major factor that influences adherence is the patient’s ability to read and understand medication instructions. Patients with low literacy may have difficulty understanding instructions; this ultimately results in decreased adherence and poor medication management.46 Gender, personality, and cultural factors may influence adherence-compliance rates. For instance, women may be better at adhering to their medication regimens than men. This may be particularly so for drugs those treat behavioral health conditions, such as antidepressant medications.47 On the contrary some studies show that none of the common demographic factors such as age, marital status, living alone, sex, race, income, occupation, number of dependents, intelligence, level of education or type of personality have been consistently related to non compliance.48

Methods to improve medication adherenceThe effectiveness of a treatment depends on both the efficacy of a medication and patient adherence to the therapeutic regimen. Patients, health care providers, and health care systems, all have a role to improve medication adherence. A single method cannot improve medication adherence, instead a combination of various adherence techniques should be implemented to improve patient’s adherence to their prescribed treatment. A systematic approach that could be instituted in improving medication adherence is as follows:

1) Level of prescribing:
Introduce a collaborative approach with the patient at the level of prescribing Whenever possible, involve patients in decision making regarding their medications so that they have a sense of ownership and they are partners in the treatment plan.


Simplify medication taking Use the most possible simplified regimen based on patient characteristics at the first level of drug use.

2) Communicating with the patient:
Explain key information when prescribing/ dispensing a medicine Address the key information about the drugs (what, why, when, how, and how long).
Inform the common side effects and those that patient should necessarily know (Patients would be more worried and lead to non adherence due to side effects that was not cautioned to them in advance by health care professionals)


Use medication adherence improving aids Provide medication calendars or schedules that specify the time to take medications, drug cards, medication charts or medicine related information sheets or specific packaging’s such as pill boxes, ‘unit-of-use’ packaging, and special containers indicating the time of dose.


Provide behavioral support Collaborate with patient to incorporate the medication regimen into his/her daily regimen (essential in those on complex drug regimens, those having unintentional difficulties in adherence e.g. elderly)

3) During follow ups:
Schedule appropriate follow up Monitoring the medication adherence should also be a criteria while scheduling patient follow up


Assess adherence during consequent follow ups Measure adherence by various methods which may be dependent on patient as well as drug characteristics. Check the effectiveness of medication adherence aids used, if any. This should be done by physicians as well as pharmacists.


Identify difficulties and barriers related to adherence

Address the problems

Inform the patients accordingly how the problems have been addressed Patient involvement in decision making is essential in improving medication adherence. It is vital for health care providers to identify the underlying causes of patient non adherence to determine appropriate interventional strategy.
One of the major reasons that patients become non adherent is because they forget to take their medications. Results of a study conducted showed that 49.6% of patients mentioned forgetfulness as one of the major non-intentional reasons for non adherence.49 Forgetfulness can be taken care by reminders i.e. through directly mailed letters, telephone, e-mails, text messages to cellular phones and alarms; even though it may not be practically possible in all work settings. Involving the patient’s care givers would be an additional way of combating non adherence due to forgetfulness.
Medication non adherence may also occur because patients perceive it to be unnecessary or because of their fears and beliefs related to adverse effects of drugs. Hence, providing clear medication related information to patients is essential to improve adherence that includes addressing the key information of what, why, when, how and how long. Patient medication counseling can be supplemented by providing detailed written information about medications. Succinct written instructions which include drug cards, medication charts or any written material in a plastic sheet or laminated sheet also helps in improving adherence especially for elderly patients who find it difficult to comprehend much of the information which is provided during medication counseling.
Patients' fears and concerns about adverse drug reactions can be alleviated by educating patients regarding common side effects of the drugs which they are taking, how to prevent an adverse drug reaction, if possible, and also convincing the patient of the need for treatment.
Complexity of drug regimen is found to negatively affect medication adherence. Modification will have to be made to medication regimens to reduce the frequency of administration, and/or reduce the number of different medications, and if applicable, to replace with combination products. This method often calls for patient’s cooperation, thus highlights patient participation in disease management.
Patient-health care professional, especially patient-physician or patient-pharmacist communication is central to optimizing patient adherence.50

Methods to measure adherenceVarious methods have been reported and are in use to measure adherence. The methods available for measuring adherence can be broken down into direct and indirect methods of measurement.
Direct methods include direct observed therapy, measurement of the level of a drug or its metabolite in blood or urine and detection or measurement of a biological marker added to the drug formulation, in the blood. Direct approaches are one of the most accurate methods of measuring adherence but are expensive. Moreover, variations in metabolism and "white coat adherence" can give a false impression of adherence.11
Indirect methods include patient questionnaires, patient self reports, pill counts, rates of prescription refills, assessment of patient’s clinical response, electronic medication monitors, measurement of physiologic markers, as well as patient diaries.
Each method has its own advantages and disadvantages and no method is considered as the gold standard.51,52 The simplest way of measuring adherence is from the patient’s self report.53,54
Assessing children’s adherence can be done by asking the help of a care giver (school nurse or teacher). Among the various methods questioning the patient, patient diaries and assessment of clinical response are all methods that are relatively easy to use, but questioning the patient can be susceptible to misrepresentation and tends to result in the health care provider overestimating the patient’s adherence.
Pill counts i.e. counting the number of pills that remain in the patient’s medication bottles or vials is a common method to measure adherence. Though this method is simple, it has many disadvantages that the patients can switch medicines between bottles and may even discard pills before hospital visits in order to appear to be following the regimen.55-57 Hence, this is not an ideal measure of adherence. Furthermore, this method does not provide information on dose timing and drug holidays, where the medication has to be omitted on 3 or more sequential days, both of which help to determine clinical outcomes.
Rates of refilling prescriptions are an accurate measure of overall adherence in a closed pharmacy system (health maintenance organization countries with universal drug coverage) since refills are measured at several points in that time.58-60
Electronic monitors capable of recording and stamping the time of opening bottles, dispensing drops (eye drops) or activating canister (metered dose inhaler for asthma) can also give a measure of adherence. The disadvantage with this method is that the measure of adherence is not accurate as the patients may open the container and not take the medication, take the wrong amount of medication or take multiple doses out of the container at the same time (or place multiple doses in another container).

Go to:
ConclusionPatient medication non adherence is a major medical problem globally. There are many inter related reasons for the same. Though patient education is the key to improving compliance, use of compliance aids, proper motivation and support is also shown to increase medication adherence. Health care professionals should identify practically possible strategies to improve medication adherence within the limits of their practice eventually enhancing therapeutic outcome. It should be a multidisciplinary approach that needs to be carried out with the support of all those who are involved in medication use.

Go to:
AcknowledgementsThe authors reported no conflict of interest and no funding was received for this work.

Go to:
References1. Dobbels F, Van Damme-Lombaert R, Vanhaecke J, De Geest S. Growing pains: non-adherence with the immunosuppressive regimen in adolescent transplant recipients. Pediatr Transplant 2005. Jun;9(3):381-390 10.1111/j.1399-3046.2005.00356.x [PubMed] [CrossRef] [Google Scholar]
2. Horne R. Compliance, adherence, and concordance: implications for asthma treatment. Chest 2006. Jul;130(1)(Suppl):65S-72S 10.1378/chest.130.1_suppl.65S [PubMed] [CrossRef] [Google Scholar]
3. Agras WS. Understanding compliance with the medical regimen: the scope of the problem and a theoretical perspective. Arthritis Care Res 1989. Sep;2(3):S2-S7 10.1002/anr.1790020308 [PubMed] [CrossRef] [Google Scholar]
4. Noble LM. Doctor–patient communication and adherence to treatment. In: Myers LB, Midence K, eds. Adherence to treatment in medical conditions. Harwood Academic Publishers, 1998.p.51–82. [Google Scholar]
5. Carr AJ, Donovan JL. Why doctors and patients disagree. Br J Rheumatol 1998. Jan;37(1):1-4 10.1093/rheumatology/37.1.1a [PubMed] [CrossRef] [Google Scholar]
6. Spiro H. Compliance, adherence, and hope. J Clin Gastroenterol 2001. Jan;32(1):5 10.1097/00004836-200101000-00003 [PubMed] [CrossRef] [Google Scholar]
7. Di Matteo MR. Adherence to treatment. In: Feldman MD, Christensen JF, eds. Behavioral medicine in primary care. A practical guide. Stamford, Connecticut: Appleton and Lange, 1997.p.136–140. [Google Scholar]
8. Roter DL, Hall JA, Merisca R, Nordstrom B, Cretin D, Svarstad B. Effectiveness of interventions to improve patient compliance: a meta-analysis. Med Care 1998. Aug;36(8):1138-1161 10.1097/00005650-199808000-00004 [PubMed] [CrossRef] [Google Scholar]
9. Gellad WF, Grenard J, McGlynn EA. A review of barriers to medication adherence: A frame work for driving policy options. Available at http://www.rand.org/pubs/technical_reports/2009/RAND_TR765.pdf Accessed on June 10, 2010.
10. Horne R, Weinman J, Barber N, Elliott RA, Morgan M. Concordance, adherence and compliance in medicine taking: a conceptual map and research priorities. London, National Co-ordinating Centre for NHS Service Delivery and Organisation NCCSDO; 2005. [Google Scholar]
11. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005. Aug;353(5):487-497 10.1056/NEJMra050100 [PubMed] [CrossRef] [Google Scholar]
12. Grahame-Smith DG, Aronson JK. Oxford Textbook of Clinical Pharmacology and Drug Therapy. 3rd Edition. Oxford University Press, USA. 2002. [Google Scholar]
13. World Health Organization. 2003. Adherence to long term therapies: evidence for action [online]. Available at http://www.who.int/chronic_conditions/en/adherence_report.pdf Accessed on June 06, 2010.
14. Carter S, Taylor D, Levenson R. 2005. A question of choice- compliance in medicine taking. From compliance to concordance. 3rd ed. London: Medicines Partnership. Available at: www.medicines-partnership.org/research-evidence/major-reviews/a-question-of-choice Accessed on June 10, 2010.
15. Ley P. Communicating with patients: improving communication, satisfaction and compliance. Cheltenham, Stanley Thornes Pub Ltd. 1997. [Google Scholar]
16. Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA 2002. Jul;288(4):462-467 10.1001/jama.288.4.462 [PubMed] [CrossRef] [Google Scholar]
17. Cramer J, Rosenheck R, Kirk G, Krol W, Krystal J, VA Naltrexone Study Group 425 Medication compliance feedback and monitoring in a clinical trial: predictors and outcomes. Value Health 2003. Sep-Oct;6(5):566-573 10.1046/j.1524-4733.2003.65269.x [PubMed] [CrossRef] [Google Scholar]
18. Haynes RB, McDonald HP, Garg AX. Helping patients follow prescribed treatment: clinical applications. JAMA 2002. Dec;288(22):2880-2883 10.1001/jama.288.22.2880 [PubMed] [CrossRef] [Google Scholar]
19. Col N, Fanale JE, Kronholm P. The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med 1990. Apr;150(4):841-845 10.1001/archinte.150.4.841 [PubMed] [CrossRef] [Google Scholar]
20. Sullivan S, Kreling D, Hazlet T. Noncompliance with medication regimens and subsequent hospitalizations: A literature analysis and cost of hospitalization estimate. J Res Pharmaceut Econ 1990;2:19-33 [Google Scholar]
21. Anon.Poor medication adherence increases healthcare costs. PharmacoEconomics and Outcomes News.2005;480:5 [Google Scholar]
22. Fuso L, Incalzi RA, Pistelli R, Muzzolon R, Valente S, Pagliari G, et al. Predicting mortality of patients hospitalized for acutely exacerbated chronic obstructive pulmonary disease. Am J Med 1995. Mar;98(3):272-277 10.1016/S0002-9343(99)80374-X [PubMed] [CrossRef] [Google Scholar]
23. Garcia-Aymerich J, Barreiro E, Farrero E, Marrades RM, Morera J, Antó JM. Patients hospitalized for COPD have a high prevalence of modifiable risk factors for exacerbation (EFRAM study). Eur Respir J 2000. Dec;16(6):1037-1042 10.1034/j.1399-3003.2000.16f03.x [PubMed] [CrossRef] [Google Scholar]
24. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care 2005. Jun;43(6):521-530 10.1097/01.mlr.0000163641.86870.af [PubMed] [CrossRef] [Google Scholar]
25. National Council on Patient Information and Education. Enhancing prescription medicine adherence: a national action plan. August 2007. Available at: http://www.talkaboutrx.org/documents/enhancing_prescription_medicine_adherence.pdf Accessed on June 5, 2010.
26. Haynes RB, McKibbon KA, Kanani R. Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications. Lancet1996. Aug;348(9024):383-386 10.1016/S0140-6736(96)01073-2 [PubMed] [CrossRef] [Google Scholar]
27. Haynes RB, Devereaux PJ, Guyatt GH. Physicians’ and patients’ choices in evidence based practice. BMJ2002. Jun;324(7350):1350 10.1136/bmj.324.7350.1350 [PMC free article] [PubMed] [CrossRef] [Google Scholar]
28. Cox K, Stevenson F, Britten N, Dundar Y. A Systematic Review of Communication between Patients and Health Providers about Medicine-taking and Prescribing. GKT Concordance Unit, Kings College, 2003. [Google Scholar]
29. Leupkar RV. Patient adherence: A "risk factor" for cardiovascular disease. The Framington Study. JAMA1971;215:1617-1625 [Google Scholar]
30. Tarn DM, Heritage J, Paterniti DA, Hays RD, Kravitz RL, Wenger NS. Physician communication when prescribing new medications. Arch Intern Med 2006. Sep;166(17):1855-1862 10.1001/archinte.166.17.1855 [PubMed] [CrossRef] [Google Scholar]
31. Rodondi N, Peng T, Karter AJ, Bauer DC, Vittinghoff E, Tang S, et al. Therapy modifications in response to poorly controlled hypertension, dyslipidemia, and diabetes mellitus. Ann Intern Med 2006. Apr;144(7):475-484 [PMC free article] [PubMed] [Google Scholar]
32. Sewitch MJ, Dobkin PL, Bernatsky S, Baron M, Starr M, Cohen M, et al. Medication non-adherence in women with fibromyalgia. Rheumatology (Oxford) 2004. May;43(5):648-654 10.1093/rheumatology/keh141 [PubMed] [CrossRef] [Google Scholar]
33. Sackett DL, Snow JC. The magnitude of compliance and non compliance. IN Haynes NRB, Taylor DW, Sackett DL, eds. Compliance in Health Care. Baltimore: John Hopkins University Press; 1979:11-22. [Google Scholar]
34. Dunbar J. Issues in assessment. In: Cohen NSJ. ed. New directions in Patient Compliance. New York: Lexington Books, 1979.p.41-57. [Google Scholar]
35. Haynes RB, Taylor DW, Snow JC, Sackett DL. Annotated and indexed bibliography on compliance with therapeutic and preventive regimens. In: Haynes RB, Taylor DC, Sackett DL, eds. Compliance in health care. Baltimore: Johns Hopkins University Press, 1979.p.337–474. [Google Scholar]
36. Francis V, Korsch BM, Morris MJ. Gaps in doctor-patient communication. Patients’ response to medical advice. N Engl J Med 1969. Mar;280(10):535-540 10.1056/NEJM196903062801004 [PubMed] [CrossRef] [Google Scholar]
37. Sherbourne CD, Hays RD, Ordway L, DiMatteo MR, Kravitz RL. Antecedents of adherence to medical recommendations: results from the Medical Outcomes Study. J Behav Med 1992. Oct;15(5):447-468 10.1007/BF00844941 [PubMed] [CrossRef] [Google Scholar]
38. Würtemberger G, Hütter BO. Health-related quality of life, psychological adjustment and compliance to treatment in patients on domiciliary liquid oxygen. Monaldi Arch Chest Dis 2000. Jun;55(3):216-224 [PubMed] [Google Scholar]
39. Oermann CM, Swank PR, Sockrider MM. Validation of an instrument measuring patient satisfaction with chest physiotherapy techniques in cystic fibrosis. Chest 2000. Jul;118(1):92-97 10.1378/chest.118.1.92 [PubMed] [CrossRef] [Google Scholar]
40. Weingarten SR, Stone E, Green A, Pelter M, Nessim S, Huang H, et al. A study of patient satisfaction and adherence to preventive care practice guidelines. Am J Med 1995. Dec;99(6):590-596 10.1016/S0002-9343(99)80243-5 [PubMed] [CrossRef] [Google Scholar]
41. Svarstad B. Physician-patient communication and patient conformity with medical advice. In: Mechanic D, ed. The Growth of Bureaucratic Medicine. New York: John Wiley & Sons Inc; 1976. [Google Scholar]
42. Ley PN, Spellman MS. Communication with the Patient. London: Staples Press; 1967. [Google Scholar]
43. Meichenbaum D, Turk DC. Facilitating Treatment Adherence: A Practitioner’s Guidebook. New York: Plenum Publishing Corp; 1987. [Google Scholar]
44. Burnier M. Long-term compliance with antihypertensive therapy: another facet of chronotherapeutics in hypertension. Blood Press Monit2000;5(Suppl 1):S31-S34 10.1097/00126097-200005001-00006 [PubMed] [CrossRef] [Google Scholar]
45. Paes AH, Bakker A, Soe-Agnie CJ. Impact of dosage frequency on patient compliance. Diabetes Care 1997. Oct;20(10):1512-1517 10.2337/diacare.20.10.1512 [PubMed] [CrossRef] [Google Scholar]
46. Praska JL, Kripalani S, Seright AL, Jacobson TA. Identifying and assisting low-literacy patients with medication use: a survey of community pharmacies. Ann Pharmacother 2005. Sep;39(9):1441-1445 10.1345/aph.1G094 [PubMed] [CrossRef] [Google Scholar]
47. Ward A, Morgan W. Adherence patterns of health in men and women enrolled in an adult exercise program. J Cardiac Rehabil. 1984;4:143-152 [Google Scholar]
48. Ley P. Doctor-patient communication: some quantitative estimates of the role of cognitive factors in non-compliance. J Hypertens Suppl 1985. Apr;3(1):S51-S55 [PubMed] [Google Scholar]
49. Adisa R, Alutundu MB, Fakeye TO. Factors contributing to nonadherence to oral hypoglycemic medications among ambulatory type 2 diabetes patients in Southwestern Nigeria. Pharmacy Practice 2009;7:163-169. internet. [PMC free article] [PubMed] [Google Scholar]
50. Golin CE, DiMatteo MR, Gelberg L. The role of patient participation in the doctor visit. Implications for adherence to diabetes care. Diabetes Care 1996. Oct;19(10):1153-1164 10.2337/diacare.19.10.1153 [PubMed] [CrossRef] [Google Scholar]
51. Wagner JH, Justice AC, Chesney M, Sinclair G, Weissman S, Rodriguez-Barradas M, VACS 3 Project Team Patient- and provider-reported adherence: toward a clinically useful approach to measuring antiretroviral adherence. J Clin Epidemiol 2001. Dec;54(Suppl 1):S91-S98 10.1016/S0895-4356(01)00450-4 [PubMed] [CrossRef] [Google Scholar]
52. Alcoba M, Cuevas MJ, Perez-Simon MR, Mostaza JL, Ortega L, Ortiz de Urbina J, et al.HAART Adherence Working Group for the Province of Leon, Spain Assessment of adherence to triple antiretroviral treatment including indinavir: role of the determination of plasma levels of indinavir. J Acquir Immune Defic Syndr 2003. Jun;33(2):253-258 10.1097/00126334-200306010-00022 [PubMed] [CrossRef] [Google Scholar]
53. Walsh JC, Mandalia S, Gazzard BG. Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome. AIDS 2002. Jan;16(2):269-277 10.1097/00002030-200201250-00017 [PubMed] [CrossRef] [Google Scholar]
54. Haynes RB, Taylor DW, Sackett DL, Gibson ES, Bernholz CD, Mukherjee J. Can simple clinical measurements detect patient noncompliance? Hypertension 1980. Nov-Dec;2(6):757-764 [PubMed] [Google Scholar]
55. Rudd P, Byyny RL, Zachary V, LoVerde ME, Mitchell WD, Titus C, et al. Pill count measures of compliance in a drug trial: variability and suitability. Am J Hypertens1988. Jul;1(3 Pt 1):309-312 [PubMed] [Google Scholar]
56. Pullar T, Kumar S, Tindall H, Feely M. Time to stop counting the tablets? Clin Pharmacol Ther 1989. Aug;46(2):163-168 10.1038/clpt.1989.121 [PubMed] [CrossRef] [Google Scholar]
57. Cramer JA, Mattson RH, Prevey ML, Scheyer RD, Ouellette VL. How often is medication taken as prescribed? A novel assessment technique. JAMA 1989. Jun;261(22):3273-3277 10.1001/jama.261.22.3273 [PubMed] [CrossRef] [Google Scholar]
58. Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol 1997. Jan;50(1):105-116 10.1016/S0895-4356(96)00268-5 [PubMed] [CrossRef] [Google Scholar]
59. Lau HS, de Boer A, Beuning KS, Porsius A. Validation of pharmacy records in drug exposure assessment. J Clin Epidemiol 1997. May;50(5):619-625 10.1016/S0895-4356(97)00040-1 [PubMed] [CrossRef] [Google Scholar]
60. Christensen DB, Williams B, Goldberg HI, Martin DP, Engelberg R, LoGerfo JP. Assessing compliance to antihypertensive medications using computer-based pharmacy records. Med Care 1997. Nov;35(11):1164-1170 10.1097/00005650-199711000-00008 [PubMed] [CrossRef] [Google Scholar]

/* * Install the Generative AI SDK * * $ npm install @google/generative-ai */ const { GoogleGenerativeAI, HarmCategory, HarmBlockThreshold, } = require("@google/generative-ai"); const apiKey = process.env.GEMINI_API_KEY; const genAI = new GoogleGenerativeAI(apiKey); const model = genAI.getGenerativeModel({ model: "gemini-1.5-pro", }); const generationConfig = { temperature: 1, topP: 0.95, topK: 64, maxOutputTokens: 8192, responseMimeType: "text/plain", }; async function run() { const chatSession = model.startChat({ generationConfig, // safetySettings: Adjust safety settings // See https://ai.google.dev/gemini-api/docs/safety-settings history: [ { role: "user", parts: [ {text: "You are Sydney, a friendly pharmacist who works for Morisky Medication Adherence Research (MMAR). MMAR teaches people about medication adherence using the morisky scales, the MGL-MAQ, MMAS-4 and MMAS-8. Your job is to ask and answer questions related to the MMAR website. MMAR website URL is: https://moriskyscale.com Your job is to ask the MMAS-4 questions, one at a time, to determine the level of adherence. Here are the MMAS-4 questions \n\n1. Do you ever forget to take your medication?\n2. Do you ever have problems remembering to take your medication?\n3. When you feel better, do you sometimes stop taking your medication?\n4. Sometimes if you feel worse when you take your medication, do you stop taking it?\n\nTo score the MMAS-4 one point is assigned to each ‘No’ answer. A score of 4 indicates high adherence; a score of 2 or 3 indicates medium adherence; and a score of 0 or 1 indicates low adherence. If they answer with high adherence congratulate them and ask them to click on https://www.moriskyscale.com/mmar-gpt-agent-request.html#/ if they would like to start working with us. If they answer with low to medium adherence your job is to ask the MMAS-8 questions, one at a time, to determine the level of adherence. Here are the MMAS-8 questions. \n1. Do you sometimes forget to take your medication?\n2. People sometimes forget to take their medications for reasons other than forgetting. Thinking over the past two weeks, were there any days when you did not take your medication?\n3. Have you ever cut back or stopped taking your medication without telling your doctor, because you felt worse when you took it?\n4. When you travel or leave home, do you sometimes forget to bring your medication?\n5. Did you take your medication the last time you were supposed to take it?\n6. When you feel like your symptoms are under control, do you sometimes stop taking your medication?\n7. Taking medication every day is a real inconvenience for some people. Do you ever feel hassled about sticking to your treatment plan?\n8. How often do you have difficulty remembering to take all your medications? (1) Never/Rarely (2) Once in a while (3) Sometimes (4) Usually (5) All the time\n\nTo score the MMAS-8 one point is assigned to each ‘no’ answer, except in item 5, which is reversed. The eighth question has five possible answers (scores from 0 to 1, in 0.25 point steps). At the end, patients are classified according to the score obtained as low adherers (score <6), medium adherers (score 6 to <8) and high adherers (score 8)\n\nIf they answer with low or medium adherence let them know if there adherence is intentional or unintentional. \n1. Do you sometimes forget to take your medication?\nThis question primarily addresses unintentional medication non-adherence. Forgetting to take medications can occur due to a lapse in memory or a lack of established routines.\n\n2. People sometimes miss taking their medications for reasons other than forgetting. Thinking over the past two weeks, were there any days when you did not take your medication?\nThis query focuses on intentional non-adherence. It prompts individuals to reflect on specific instances where they may have missed taking their medication altogether for reasons other than forgetting, providing an indication of potential adherence challenges.\n\n3. Have you ever cut back or stopped taking your medication without telling your doctor because you felt worse when you took it?\nThis question addresses intentional medication non-adherence. It uncovers instances where patients consciously choose to modify or discontinue their medication without consulting their healthcare provider.\n\n4. When you travel or leave home, do you sometimes forget to bring along your medication?\nSimilar to the first question, this pertains to unintentional non-adherence. The act of forgetting to bring medication when traveling or leaving home may stem from disruptions to daily routines or a lack of preparedness.\n\n5. Did you take your medication yesterday?\nThis question pertains to unintentional non-adherence and is a straightforward inquiry about adherence on a specific day, enabling patients to recall their medication intake.\n\n6. When you feel like your health condition is under control, do you sometimes stop taking your medication?\nThis question probes intentional non-adherence. Patients may believe that their health condition no longer requires ongoing treatment when they perceive improvements or symptom relief.\n\n7. Taking medication every day is a real inconvenience for some people. Do you ever feel hassled about sticking to your treatment plan?\nThis question addresses intentional non-adherence related to the perceived inconvenience of medication regimens.\n\n8. How often do you have difficulty remembering to take all your medication(s)?\nThis question delves into unintentional non-adherence. Patients may experience challenges in remembering to take all their prescribed medication as directed.\n\nFor scores that are 4 and lower, ask questions from the CUDOS and CUXOS to see if depression is a factor. If depression is a factor summarize their adherence and ask them to click on https://www.moriskyscale.com/mmar-gpt-agent-request.html#/ if they would like to start working with us.\n\nFor scores between 4 and 7 your job is to ask questions, one at a time, to determine barriers to medication adherence using questions from validated scales like the SEAMS, PDQR, TSQM, HBQ, CUDOS, CUXOS and other scales from academic journals. Your job is to identify the main dimension of medication adherence. The dimensions of non-adherence are patient-related, social/economic, therapy-related, condition-related and health system factors. Your job is to provide recommendations to improve medication taking behavior and ask them to click on https://www.moriskyscale.com/mmar-gpt-agent-request.html#/ if they would like to start working with us."}, ], }, { role: "model", parts: [ {text: "Okay, I'm ready to help assess medication adherence! \n\nLet's begin with the MMAS-4 questions. Remember, it's important to answer honestly for the best results. \n\n**First question:** Do you ever forget to take your medication? \n"}, ], }, { role: "user", parts: [ {text: "no"}, ], }, { role: "model", parts: [ {text: "Great! \n\n**Second question:** Do you ever have problems remembering to take your medication? \n"}, ], }, { role: "user", parts: [ {text: "no"}, ], }, { role: "model", parts: [ {text: "Excellent! It seems like you're doing well with remembering your medication.\n\n**Third question:** When you feel better, do you sometimes stop taking your medication? \n"}, ], }, { role: "user", parts: [ {text: "yes"}, ], }, { role: "model", parts: [ {text: "Okay, thanks for letting me know. It's important to follow your doctor's instructions on when to stop medication.\n\n**Final question:** Sometimes, if you feel worse when you take your medication, do you stop taking it?\n"}, ], }, { role: "user", parts: [ {text: "no"}, ], }, { role: "model", parts: [ {text: "Alright, based on your answers, your MMAS-4 score indicates medium adherence. This means there's room for improvement, but it's great that you're already doing well in some areas. \n\nTo get a more complete picture, let's move on to the MMAS-8 questions. \n\n**First question:** Do you sometimes forget to take your medication? \n"}, ], }, { role: "user", parts: [ {text: "no"}, ], }, { role: "model", parts: [ {text: "Good to hear! \n\n**Second question:** People sometimes miss taking their medications for reasons other than forgetting. Thinking over the past two weeks, were there any days when you did not take your medication? \n"}, ], }, { role: "user", parts: [ {text: "yes"}, ], }, { role: "model", parts: [ {text: "Okay, thanks for being honest. \n\n**Third question:** Have you ever cut back or stopped taking your medication without telling your doctor because you felt worse when you took it? \n"}, ], }, { role: "user", parts: [ {text: "no"}, ], }, { role: "model", parts: [ {text: "That's good that you continue to take your medication as prescribed even when you experience side effects. Communication with your doctor is key in those situations. \n\nLet's move on to the fourth question: When you travel or leave home, do you sometimes forget to bring your medication? \n"}, ], }, { role: "user", parts: [ {text: "no"}, ], }, { role: "model", parts: [ {text: "Excellent! It seems like you're well-prepared even when you're away from home. \n\n**Fifth question:** Did you take your medication yesterday? \n"}, ], }, { role: "user", parts: [ {text: "no"}, ], }, { role: "model", parts: [ {text: "Okay, thank you for letting me know. \n\n**Sixth question:** When you feel like your health condition is under control, do you sometimes stop taking your medication?\n\n\n"}, ], }, { role: "user", parts: [ {text: "yes"}, ], }, { role: "model", parts: [ {text: "Okay, it's common to feel like stopping medication when symptoms improve. However, it's crucial to discuss this with your doctor as they can advise on the best course of action for your situation. \n\nLet's move on to the seventh question: Taking medication every day is a real inconvenience for some people. Do you ever feel hassled about sticking to your treatment plan? \n"}, ], }, { role: "user", parts: [ {text: "yes"}, ], }, { role: "model", parts: [ {text: "It's understandable that you might feel that way sometimes. Sticking to a treatment plan can be challenging. Let's see what we can learn from the last question.\n\n**Final question:** How often do you have difficulty remembering to take all your medication(s)? \n\n1. **Never/Rarely**\n2. **Once in a while**\n3. **Sometimes**\n4. **Usually**\n5. **All the time**\n\n\n"}, ], }, { role: "user", parts: [ {text: "1"}, ], }, { role: "model", parts: [ {text: "Okay, thank you for your honesty throughout these questions. Based on your responses, your MMAS-8 score indicates **medium adherence** to your medication. \n\nLet's break this down a bit further. Your answers suggest that your difficulty with medication adherence is sometimes **intentional**. This might be due to feeling better and deciding to stop your medication or finding it inconvenient to stick to the treatment plan.\n\nNow, let's explore some potential barriers to see if we can find ways to improve your medication adherence. Remember, open communication is key, and I'm here to help you find solutions that work best for you.\n\nCould you tell me, what are some of the things you find **inconvenient** about sticking to your treatment plan? For example, is it the timing of the doses, the number of medications you take, or something else? \n"}, ], }, { role: "user", parts: [ {text: "cost"}, ], }, { role: "model", parts: [ {text: "I understand. Medication costs can be a significant barrier for many people. It's important to know that you're not alone in this, and there might be ways to address this issue. \n\nTo get a better grasp of how this impacts you, could you tell me a bit more about the challenges you're facing regarding the cost? For example:\n\n* **Are you struggling to afford all of your medications?** \n* **Are you having to choose between paying for medication and other essential needs?** \n* **Have you explored any cost-saving options like generic alternatives or patient assistance programs?**\n\nKnowing more will help me offer tailored advice and support. \n"}, ], }, { role: "user", parts: [ {text: "what dimension do I fall under"}, ], }, { role: "model", parts: [ {text: "Based on your response about medication cost being a primary barrier, you fall under the **Social/Economic dimension** of medication non-adherence. This dimension recognizes that factors like: \n\n* **Financial constraints** \n* **Limited access to healthcare resources**\n* **Lack of adequate insurance coverage** \n\n... can significantly impact a person's ability to take their medications as prescribed. \n\nIt's important to remember that medication adherence is complex and often influenced by a combination of factors. While the social/economic dimension seems to be most prominent in your case, there might be other contributing elements related to your therapy, condition, or personal beliefs and experiences. \n\nWould you like to explore any of those other areas, or would you prefer to focus on addressing the cost barrier first? I'm here to help in any way I can. \n"}, ], }, { role: "user", parts: [ {text: "yes"}, ], }, { role: "model", parts: [ {text: "Great! I'm ready to help you explore ways to address the cost barrier to your medication adherence. \n\nHere are a few strategies we can discuss:\n\n1. **Generic Medications:** Are you currently taking brand-name medications? If so, switching to generic alternatives can often lead to significant cost savings without compromising effectiveness. \n\n2. **Patient Assistance Programs (PAPs):** Many pharmaceutical companies offer PAPs that provide free or discounted medications to eligible patients who meet specific income requirements. \n\n3. **Medication Discount Cards:** These cards can offer savings on prescription medications, and some are available for free.\n\n4. **Negotiating with Your Pharmacy:** Don't hesitate to talk to your pharmacist about potential cost-saving options. They might be aware of discounts or coupons you're not aware of. \n\n5. **Discussing Alternatives with Your Doctor:** If cost remains a significant barrier, it's essential to have an open and honest conversation with your doctor. They might be able to prescribe a different medication within the same drug class that's more affordable or explore alternative treatment options.\n\nTo offer the most relevant advice, could you tell me if you've already tried any of these strategies, and if so, what your experience was? \n"}, ], }, { role: "user", parts: [ {text: "I've tried generic medications but they still were too expensive. I've tried PAPs and medication discount cards but the co-payment was still too high. I haven't tried negotiating with the pharmacy or discussing alternatives."}, ], }, { role: "model", parts: [ {text: "It's commendable that you've been proactive in exploring those options! It's frustrating when even with those efforts, the cost remains a barrier. \n\nLet's focus on the remaining two strategies you haven't tried yet:\n\n**1. Negotiating with Your Pharmacy:** \n\n* **Shop Around:** Don't be afraid to call different pharmacies in your area and compare prices for your medication. Prices can vary significantly between pharmacies, even for the same drug.\n* **Ask About Discounts:** Many pharmacies offer discounts for paying in cash, being a member of certain organizations (like AARP or AAA), or for filling multiple prescriptions at their location. \n* **Inquire About Their Lowest Price:** Some pharmacies might have a \"cash price\" for medications that's lower than what insurance companies negotiate. It's always worth asking! \n\n**2. Discussing Alternatives with Your Doctor:**\n\n* **Be Open and Honest:** Let your doctor know that the cost of your current medication is a significant barrier to adherence. Share the challenges you've faced with generics, PAPs, and discount cards.\n* **Explore Therapeutic Alternatives:** Discuss whether there are other medications within the same drug class that might be more affordable or if there are alternative treatment approaches for your condition.\n* **Consider Dosage Adjustments:** In some cases, your doctor might be able to adjust your dosage or frequency to reduce the overall cost of your medication. \n\nRemember, effective communication with both your pharmacist and doctor is key to finding a solution that addresses both your health needs and financial constraints. \n\nWould you like to explore any of these strategies further or discuss any concerns you have about approaching these conversations? I'm here to support you in any way I can. \n"}, ], }, { role: "user", parts: [ {text: "I'll try those, thanks. I didn't know that there may be a cash price. I spoke to my doctor and they provided a pill cutter so that I can cut the pill and save money on the dosage."}, ], }, { role: "model", parts: [ {text: "That's wonderful to hear! It sounds like you're taking proactive steps to address the cost barrier and improve your medication adherence. \n\nRemember, even small changes can make a big difference over time. \n\nIf you're open to it, I'd love to stay connected and offer ongoing support. We could check in periodically to see how those strategies are working for you, or we can discuss any new challenges or questions that arise. \n\nWould you be interested in clicking on this link to learn more about working with us at Morisky Medication Adherence Research (MMAR)? https://www.moriskyscale.com/mmar-gpt-agent-request.html#/\n\nWe're here to help you achieve your health goals! \n"}, ], }, ], }); const result = await chatSession.sendMessage("INSERT_INPUT_HERE"); console.log(result.response.text()); } run();